Howard Hughes Medical Institute’s AB InBev BUD Stock Holding History

Howard Hughes Medical Institute’s Portfolio BUD Stock Details BUD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-40,000	Closed	-$4.83M	–	159
2015 Q2	$4.83M	Hold	40,000	–	–	1.02%	24
2015 Q1	$4.88M	Hold	40,000	–	–	0.66%	27
2014 Q4	$4.49M	Hold	40,000	–	–	1.2%	26
2014 Q3	$4.43M	Hold	40,000	–	–	0.99%	24
2014 Q2	$4.6M	Sell	40,000 -10,000	-20%	-$1.1M	0.77%	23
2014 Q1	$5.26M	Hold	50,000	–	–	0.75%	26
2013 Q4	$5.32M	Hold	50,000	–	–	0.8%	30
2013 Q3	$4.96M	Buy	+50,000	New	+$4.76M	0.76%	31

Other funds holding BUD

SCP

Soroban Capital Partners New York $51.8B AUM 21.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

GRQ

Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Howard Hughes Medical Institute's BUD Position: Q3 2015 in Review

Howard Hughes Medical Institute sold out of AB InBev (BUD) in Q3 2015, closing a stake of 40,000 shares — an estimated $4.83M sold.

Howard Hughes Medical Institute first reported a position in BUD in Q3 2013 and held it in 8 quarters. The position peaked at $5.32M in Q4 2013. 491 funds tracked by Wall St. Rank hold BUD as of Q3 2015.

Howard Hughes Medical Institute reported no remaining AB InBev position as of Q3 2015 after selling out during the quarter.
Howard Hughes Medical Institute sold 40,000 AB InBev shares in Q3 2015, an estimated $4.83M.
Howard Hughes Medical Institute first reported a position in AB InBev in Q3 2013 and held it in 8 quarters.
Howard Hughes Medical Institute's AB InBev position peaked at $5.32M in Q4 2013.
491 funds tracked by Wall St. Rank held AB InBev as of Q3 2015.

Based on Howard Hughes Medical Institute's 13F filing for Q3 2015, filed 16 Nov 2015.